Notice of final decisions to amend (or not amend) the current Poisons Standard
This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS and 42ZCZX, this notice publishes the:
- decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR and 42ZCZU;
- reasons for those final decisions; and
- date of effect of those decisions.
Final decision in relation to nitrous oxide
Note that the final decision for nitrous oxide is not published in this notice. The final decision for nitrous oxide has been delayed, and is anticipated for publication in late September.
Final decisions and reasons
We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au (for substances referred to the ACMS or Joint ACCS-ACMS) or chemicals.scheduling@health.gov.au (for substances referred to the ACCS).
Contents
- 1 Notice of final decisions to amend (or not amend) the current Poisons Standard
- 2 Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #33, March 2021)
- 2.1 Final decision in relation to metoclopramide
- 2.2 Final decision in relation to chloramphenicol
- 2.3 Final decision in relation to prochlorperazine
- 2.4 Final decision in relation to processed Aconitum carmichaelii
- 3 Final decisions on proposed amendments referred to the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #27, March 2021)
- 3.1 Final decision in relation to kambo
- 3.2 Final decision in relation to lidocaine
- 3.3 Final decision in relation to hemp seed oil
- 4 Final decisions on proposed amendments referred to the Advisory Committee on Chemicals Scheduling (ACCS #30, March 2021)
- 4.1 Final decision in relation to lead (in paint)
- 4.2 Final decision in relation to cyflumetofen
- 4.3 Final decision in relation to isocycloseram
- 4.4 Final decision in relation to 1,4-benzenediamine, 2-(methoxymethyl)